Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Paraneoplastic Necrotizing Autoimmune Myopathy in a Patient Undergoing Laparoscopic Pancreatoduodenectomy for Distal Cholangiocarcinoma.

van Dijk S, van der Kooi AJ, Aronica E, van Gulik TM, Busch OR, Besselink MG.

Case Rep Gastroenterol. 2016 Oct 6;10(3):525-530. eCollection 2016 Sep-Dec.

2.

Polymyositis anti-SRP antibodies and pregnancy about 2 cases.

Ousmane C, Makhtar BE, Fatoumata B, Massi GD, Lémine DS, Soda DM, Dieynaba SA, Anna B, Bouna SL, Moustapha N, Gallo DA, Mansour NM.

Pan Afr Med J. 2016 Jul 1;24:192. eCollection 2016.

3.

Idiopathic Inflammatory Myopathies: Clinical Approach and Management.

Malik A, Hayat G, Kalia JS, Guzman MA.

Front Neurol. 2016 May 20;7:64. doi: 10.3389/fneur.2016.00064. eCollection 2016. Review.

4.

Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.

Pinal-Fernandez I, Parks C, Werner JL, Albayda J, Paik J, Danoff SK, Casciola-Rosen L, Christopher-Stine L, Mammen AL.

Arthritis Care Res (Hoboken). 2017 Feb;69(2):263-270. doi: 10.1002/acr.22920. Epub 2016 Dec 31.

PMID:
27111848
5.

Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan.

Kawasumi H, Gono T, Kawaguchi Y, Kuwana M, Kaneko H, Katsumata Y, Kataoka S, Hanaoka M, Yamanaka H.

Biomed Res Int. 2016;2016:9163201. doi: 10.1155/2016/9163201. Epub 2016 Jan 26.

6.

Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.

Apiwattanakul M, Milone M, Pittock SJ, Kryzer TJ, Fryer JP, O'toole O, Mckeon A, Lennon VA.

Muscle Nerve. 2016 Jun;53(6):925-32. doi: 10.1002/mus.24970. Epub 2016 Feb 5.

7.

Idiopathic inflammatory myopathies.

Dimachkie MM, Barohn RJ, Amato AA.

Neurol Clin. 2014 Aug;32(3):595-628, vii. doi: 10.1016/j.ncl.2014.04.007. Review.

8.

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, Maisonobe T, Dubourg O, Behin A, Laforet P, Stojkovic T, Eymard B, Costedoat-Chalumeau N, Campana-Salort E, Tournadre A, Musset L, Bader-Meunier B, Kone-Paut I, Sibilia J, Servais L, Fain O, Larroche C, Diot E, Terrier B, De Paz R, Dossier A, Menard D, Morati C, Roux M, Ferrer X, Martinet J, Besnard S, Bellance R, Cacoub P, Arnaud L, Grosbois B, Herson S, Boyer O, Benveniste O; French Myositis Network.

Medicine (Baltimore). 2014 May;93(3):150-7. doi: 10.1097/MD.0000000000000028.

9.

Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.

Aggarwal R, Bandos A, Reed AM, Ascherman DP, Barohn RJ, Feldman BM, Miller FW, Rider LG, Harris-Love MO, Levesque MC; RIM Study Group, Oddis CV.

Arthritis Rheumatol. 2014 Mar;66(3):740-9. doi: 10.1002/art.38270.

10.

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.

Drouot L, Allenbach Y, Jouen F, Charuel JL, Martinet J, Meyer A, Hinschberger O, Bader-Meunier B, Kone-Paut I, Campana-Salort E, Eymard B, Tournadre A, Musset L, Sibilia J, Marie I, Benveniste O, Boyer O; French Myositis Network [CN].

Arthritis Res Ther. 2014 Feb 3;16(1):R39. doi: 10.1186/ar4468.

11.

Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.

Huber AM, Mamyrova G, Lachenbruch PA, Lee JA, Katz JD, Targoff IN, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Care Res (Hoboken). 2014 May;66(5):732-40. doi: 10.1002/acr.22212.

12.

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis.

Cruellas MG, Viana Vdos S, Levy-Neto M, Souza FH, Shinjo SK.

Clinics (Sao Paulo). 2013 Jul;68(7):909-14. doi: 10.6061/clinics/2013(07)04.

13.

The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.

Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jul;92(4):223-43. doi: 10.1097/MD.0b013e31829d08f9.

14.

Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease.

Cordiali-Fei P, Mussi A, D'Agosto G, Trento E, Bordignon V, Trincone S, Vento A, Sperduti I, Cristaudo A, Ensoli F.

Clin Dev Immunol. 2013;2013:390563. doi: 10.1155/2013/390563. Epub 2013 May 29.

15.

Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.

Doré A, Lucas M, Ivanco D, Medsger TA Jr, Domsic RT.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1385-9. doi: 10.1002/acr.21964.

16.

Clinical and pathological roles of Ro/SSA autoantibody system.

Yoshimi R, Ueda A, Ozato K, Ishigatsubo Y.

Clin Dev Immunol. 2012;2012:606195. doi: 10.1155/2012/606195. Epub 2012 Dec 6. Review.

17.

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.

Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jan;92(1):25-41. doi: 10.1097/MD.0b013e31827f264d.

18.

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.

Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE; RIM Study Group.

Arthritis Rheum. 2013 Feb;65(2):314-24. doi: 10.1002/art.37754.

19.

Idiopathic inflammatory myopathies.

Dimachkie MM, Barohn RJ.

Semin Neurol. 2012 Jul;32(3):227-36. doi: 10.1055/s-0032-1329201. Epub 2012 Nov 1. Review.

20.

Polymyositis and dermatomyositis: Disease spectrum and classification.

Raychaudhuri SP, Mitra A.

Indian J Dermatol. 2012 Sep;57(5):366-70. doi: 10.4103/0019-5154.100477.

Supplemental Content

Support Center